This article presents an analysis of drugs used for gallbladder diseases in the local pharmaceutical market. The study utilizes data registered in 2023-2025 based on the State Register of the Republic of Uzbekistan. The obtained data demonstrate the need to expand the range of these types of drugs in domestic production.